BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $77,862 | +55.5% | 1,232 | +10.7% | 0.01% | +57.1% |
| Q1 2023 | $50,074 | +2.7% | 1,113 | 0.0% | 0.01% | -12.5% |
| Q4 2022 | $48,761 | -78.8% | 1,113 | -68.1% | 0.01% | -78.9% |
| Q3 2022 | $230,000 | +30.7% | 3,486 | 0.0% | 0.04% | +35.7% |
| Q2 2022 | $176,000 | -21.1% | 3,486 | 0.0% | 0.03% | -6.7% |
| Q1 2022 | $223,000 | -40.2% | 3,486 | 0.0% | 0.03% | -36.2% |
| Q4 2021 | $373,000 | +4.2% | 3,486 | 0.0% | 0.05% | -4.1% |
| Q3 2021 | $358,000 | +16.6% | 3,486 | 0.0% | 0.05% | +16.7% |
| Q2 2021 | $307,000 | -4.4% | 3,486 | +5.6% | 0.04% | -12.5% |
| Q1 2021 | $321,000 | -10.3% | 3,300 | +3.3% | 0.05% | -15.8% |
| Q4 2020 | $358,000 | -24.2% | 3,196 | -37.3% | 0.06% | -36.7% |
| Q3 2020 | $472,000 | +50.8% | 5,095 | +26.9% | 0.09% | +36.4% |
| Q2 2020 | $313,000 | – | 4,015 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |